FDA issues final rule on clinical trials diversity

30 settembre 2025 Riportato dall'IA

The U.S. Food and Drug Administration has finalized a rule requiring drug sponsors to submit diversity action plans for clinical trials. This aims to ensure better representation of underrepresented groups in medical research. The rule takes effect in 2025.